Cookie Settings
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Other cookies are those that are being identified and have not been classified into any category as yet.

No cookies to display.

Kenya

The Medicines Patent Pool remains committed to engage with people at the country level so that through collaboration our work meets the needs of people.

We are pleased to share with you our  site visit, where we bring you the Kenyan perspective. Kenya has benefited from MPP’s work since the onset and the country is included in all MPP’s licences[1]. Here you will hear the Kenyan perspective on access to medicines with a focus on challenges and opportunities regarding quality, affordability, availability, equity, transparency, the role of generics and opportunities for local production.

Due to the COVID-19 situation, we were not able to go to Kenya physically but, through our partner on the ground NEPHAK, we are recording a series of interviews that we aim to share on this page. Through this online channel, you’ll hear from partners working very hard to support access to essential medicines in Kenya, and from beneficiaries for whom this has made a huge difference. More videos will be added as they are being put together so stay tuned for more!

Click to see MPP’s work in licensing and supplying essential medicines in Kenya:

Better HIV treatment options for children: Jerop’s story

Access to paediatric HIV drug formulations: Nancy’s perspective

 


Read our stories from Kenya

Keyword


[1] Kenya non inclusion in the licence for ravidasvir is complemented by inclusion in the Presidio/DNDi licence. Go to MedsPaL for more information.

MPP Logo

Subscribe to our Newsletter

Founded & funded by

Unitaid Logo

Other funders